Emerging infectious diseases represent a significant threat to public health. This broad category encompasses diseases that are newly discovered and characterized (e.g., Hepatitis C, HIV) as well as diseases that have re-emerged after a period of low or intermittent activity (e.g., Yellow fever, Dengue). Many of these diseases disproportionally affect great numbers of people in the developing world. There is, however, an increasing inter-relatedness between diseases considered endemic in foreign countries and emergence of these diseases in North America. Two examples of this trend include outbreaks of West Nile virus and Dengue virus in the United States.

Najít Technologies, Inc. (NTI) is dedicated to developing vaccines for these diseases utilizing our proprietary vaccine development platform.